Digital health products that improve health outcomes and patient quality of life.
"I’m really liking how mindful you are of people’s feelings and thoughts, and what that looks like putting it into an app."
"I think it hits the head on the nail to have a AI as your buddy, rather than having only family and caregiver — take the burden out of them it's a really good idea."
“When you have anxiety, you’re short of breath and feel like you’re gonna die… I haven’t had those issues in a while now.”
Pfizer partnership
In partnership with Pfizer, Alex Therapeutics has designed, built and clinically tested a digital smoking cessation program, with pivotal trial results due to be published in 2024.
Open for partnership
In collaboration with a leading medical university research group, Alex Therapeutics has designed a digital OCD intervention with randomized controlled trials showing it significantly reduces OCD symptoms and is non-inferior to in-person therapy.
We're a pioneer in the field of digital therapeutics, having built and launched multiple digital interventions since 2018.
Each patient population and treatment has unique characteristics, and often the unmet needs of patients differ. Our modules can be easily customized and combined into a custom-made app, with white-label options available.
Alex Therapeutics is ISO-27001 certified and our team is experienced in navigating medical device regulations and bringing regulated SaMD products to market, globally.
One of the biggest challenges for digital products is engagement - our design and development team are specialists in gamification, with our app engagement far superior to competition.
Our in-house development team ensure that we are building compliantly on top of the latest technology leveraging generative AI, bring a better user experience to the next generation of therapy companions.
